Latest blog articles

  • international law

    Genocide in Gaza?

    A brief explainer about the ICJ case brought by South Africa against Israel

    On 29 December, almost three months after the 7 October Hamas attacks on Israel and the ensuing Israeli military strikes on the Gaza Strip, which had by then resulted in the deaths of more than 21,000 people and more than...

  • Officially supported export credits are instruments that governments can use to boost or support their exports, either through insurances, loans or guarantees. Most governments provide this support through Export Credit Agencies (ECAs), the first of which were founded in the 1920s (Stephens, 1999).

  • In her recent book “The Deficit Myth” star economist Stephanie Kelton tells us why economists should not worry too much about sovereign debt and deficits. But is that the same for lawyers? And are all countries truly treated equally?

  • Hugo Grotius

    To any international lawyer, Hugo de Groot (10 April 1583 – 28 August 1645), usually referred to by his Latin name as Hugo Grotius, does not need any introduction. He is generally seen as the “father of public international law”, often together with Francisco De Vitoria (1483-1546) and Alberico...

  • How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.

  • It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...

  • Today, on Human Rights Day, the Peace Palace in The Hague will be the venue of the somewhat ironic spectacle of a Nobel Peace Prize laureate and global icon of human rights leading her country’s defence against allegations of genocide, the most serious violation of human rights possible.

  • Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...